NextPlat (NASDAQ:NXPL) Stock Rating Upgraded by Zacks Research

NextPlat (NASDAQ:NXPL) was upgraded by analysts at Zacks Research to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

A number of other research analysts have also weighed in on NXPL. Litchfield Hills Research began coverage on NextPlat in a report on Wednesday. They issued a “buy” rating and a $11.00 target price on the stock. Weiss Ratings upgraded NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $11.00.

NextPlat Trading Down 4.4%

NASDAQ:NXPL opened at $6.15 on Thursday. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.56 and a quick ratio of 2.12. NextPlat has a one year low of $3.38 and a one year high of $11.10. The company has a market cap of $16.67 million, a PE ratio of -1.42 and a beta of 1.90. The firm has a 50-day moving average of $6.39 and a 200-day moving average of $5.93.

NextPlat (NASDAQ:NXPL) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. The business had revenue of $9.86 million during the quarter. NextPlat had a negative net margin of 23.14% and a negative return on equity of 58.05%. As a group, equities research analysts expect that NextPlat will post -0.55 EPS for the current fiscal year.

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent SEC filing. 1.30% of the stock is currently owned by institutional investors.

Key NextPlat News

Here are the key news stories impacting NextPlat this week:

• Positive Sentiment: Litchfield Hills Research initiated coverage on NextPlat with a Buy rating and a $11.00 price target, suggesting substantial upside potential. Street Insider article
• Positive Sentiment: The analyst sees NextPlat moving toward profitability, forecasting FY2027 EPS of $0.57 and positive quarterly EPS in 2027, which may improve longer-term sentiment. Benzinga article
• Neutral Sentiment: New earnings estimates for FY2026 (-$0.55 EPS) and Q2 2026 (-$0.21 EPS) still indicate losses in the near term, limiting immediate upside. Tickerreport article
• Neutral Sentiment: Short interest data showed a decline earlier in the month, but the most recent update reported 0 shares short, making the data unusual and hard to interpret for trading impact. American Banking News article
• Negative Sentiment: The latest analyst estimates still call for losses through most of 2026, including Q3 2026 EPS of $0.00 and Q4 2026 EPS of $0.07, so investors may remain cautious about near-term earnings power. Benzinga article

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.